Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, announced that the US Food and Drug Administration (FDA) has cleared the ...
Wearable devices have pulled terms like "REM sleep" from scientific literature to daily discussion points. But what can ...
China: A recent study published in the Journal of the American Heart Association has unveiled a compelling association ...
So of course, when new devices pop up on the scene, I am always eager to test them. Enter: RingConn Gen 2 ($299). Released in ...
Sleep Apnea Therapy System Market. Key market drivers for Sleep Apnea Therapy System Market include rising prevalence of sleep apnea disorders, growing awa ...
Medical device company ResMed (NYSE:RMD) announced better-than-expected revenue in Q4 CY2024, with sales up 10.3% year on ...
ResMed stock is down today, even though the maker of CPAPs and other respiratory treatment devices had Street-beating Q2 ...
The RingConn Gen 2 is one of the three recently launched subscription-free smart rings vying for the title of best Oura Ring ...
CR rates new and older models to help you choose the best versionFrom left: Apple Watch Series 10, Ultra 2, and SE.By ...
Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...
The great quarter was driven by high demand for sleep-related products and growth in digital health solutions. As a specialist in sleep and respiratory health, ResMed built its reputation through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback